Paclitaxel, Bevacizumab And Adjuvant Intraperitoneal Carboplatin in Treating Patients Who Had Initial Debulking Surgery for Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Mark Morgan
Gynecologic Oncology Group
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
19 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Kawasaki Medical School
Okayama-Ken, Kurashiki, Japan
- Saitama Medical University International Medical Center
Saitama, Japan
- University of California Medical Center at Irvine-Orange Campus
Orange, California, United States
- University of Chicago
Chicago, Illinois, United States
- University of Iowa Hospitals and Clinics
Iowa City, Iowa, United States
- Johns Hopkins University/sidney Kimmel Cancer Center
Baltimore, Maryland, United States
- Cooper Hospital University Medical Center
Camden, New Jersey, United States
- Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States
- Riverside Methodist Hospital
Columbus, Ohio, United States
- Cancer Care Associates-Midtown
Tulsa, Oklahoma, United States
- Tulsa Cancer Institute
Tulsa, Oklahoma, United States
- Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States
- Gynecologic Oncology Group
Philadelphia, Pennsylvania, United States
- Women and Infants Hospital
Providence, Rhode Island, United States
- M D Anderson Cancer Center
Houston, Texas, United States
- Fred Hutchinson Cancer Research Center/university of Washington Cancer Consortium
Seattle, Washington, United States
- Pacific Gynecology Specialists
Seattle, Washington, United States
- Seattle Cancer Care Alliance
Seattle, Washington, United States
- University of Washington Medical Center
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2004
- Primary completion
- 31 May 2011
- Completion
- —
- Last update posted
- 22 Jul 2019
- Registered enrollment
- 113
- Registry id
- NCT00079430
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.